Dupixent gets closer to EU approval as the FDA delays its decision on COPD
The CHMP has given a positive recommendation to Dupixent for COPD while the FDA has delayed its verdict from June to September.
The CHMP has given a positive recommendation to Dupixent for COPD while the FDA has delayed its verdict from June to September.
What's Your Reaction?
